www.fdanews.com/articles/158364-astrazeneca-starts-olaparib-in-phase-iii-for-ovarian-cancer

Astrazeneca Starts Olaparib in Phase III for Ovarian Cancer

September 4, 2013

AstraZeneca has begun a Phase III trial of olaparib for BRCA-mutated ovarian cancer.
The Pharma Letter